Title

Individualised Dosing of Amikacin in Neonates

Document Type

Letter to the Editor

Publication Date

12-2009

Abstract

We thank van den Anker and Allegaert for their comments on our recent paper (1) regarding individualised dosing of amikacin in neonates. We are particularly pleased at the recognition given to the pharmacodynamic considerations, because this is where we consider the most mileage can to be made in improving aminoglycoside drug regimens.

DOI

10.1007/s00228-009-0691-y

Find in your library

Off-Campus WSU Users


Share

COinS